Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density

被引：0
作者：
K. E. Naylor
M. Bradburn
M. A. Paggiosi
F. Gossiel
N. F. A. Peel
E. V. McCloskey
J. S. Walsh
R. Eastell
机构：
[1] University of Sheffield,Academic Unit of Bone Metabolism, The Mellanby Centre for Bone Research
[2] University of Sheffield,Clinical Trials Research Unit, School of Health and Related Research
[3] Metabolic Bone Centre,undefined
[4] Sheffield Teaching Hospitals NHS Foundation Trust,undefined
[5] Northern General Hospital Sheffield,undefined
[6] Centre for Integrated Research into Musculoskeletal Ageing,undefined
来源：
Osteoporosis International | 2018年 / 29卷
关键词：
Alendronate; Bone density; Bone markers; Ibandronate; Risedronate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1407 / 1417
页数：10
相关论文
共 297 条
[41]  
Bauer DC(2013)BMD changes and predictors of increased bone loss in postmenopausal women after a 5-year course of alendronate J Bone Miner Res 28 1319-1327
[42]  
Russell RG(undefined)undefined undefined undefined undefined-undefined
[43]  
Watts NB(undefined)undefined undefined undefined undefined-undefined
[44]  
Ebetino FH(undefined)undefined undefined undefined undefined-undefined
[45]  
Rogers MJ(undefined)undefined undefined undefined undefined-undefined
[46]  
Nancollas GH(undefined)undefined undefined undefined undefined-undefined
[47]  
Tang R(undefined)undefined undefined undefined undefined-undefined
[48]  
Phipps RJ(undefined)undefined undefined undefined undefined-undefined
[49]  
Henneman Z(undefined)undefined undefined undefined undefined-undefined
[50]  
Gulde S(undefined)undefined undefined undefined undefined-undefined
12345678910